99% Invisible cover image

Orphan Drugs

99% Invisible

00:00

Key Incentives of the Orphan Drug Act

Dan explains market exclusivity, subsidies, and the seven-year monopoly that incentivized rare-disease drug development.

Play episode from 14:56
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app